On Mar. 24, 2020, bioMerieux announced that BioFire Diagnostics, its subsidiary specialized in syndromic infectious disease testing, had…
On Mar. 24, 2020, Mesa Biotech announced it had received Emergency Use Authorization (EUA) from the FDA for…
On Mar. 24, 2020, Windtree Therapeutics announced it will study its proprietary KL4 surfactant to potentially mitigate the…
On Mar. 21, 2020, the FDA issued the first emergency use authorization for a point-of-care COVID-19 diagnostic for…
On Mar. 20, 2020, Bellerophon Therapeutics announced the U.S. Food and Drug Administration (FDA) had granted emergency expanded…
On Mar. 20, 2020, the U.S. Food and Drug Administration (FDA) issued a new policy that allowed manufacturers…
On Mar. 19, 2020, Mylan announced it had restarted production of hydroxychloroquine sulfate tablets at its West Virginia…
On Mar. 19, 2020, Abbott announced the FDA has issued Emergency Use Authorization (EUA) for the company’s molecular…
On Mar. 19, 2020, Roche announced it was working with the U.S. Food & Drug Administration (FDA) to…
On Mar. 19, 2020, Gilead Sciences announced the U.S. Food and Drug Administration (FDA) had approved a supplemental…
On Mar. 18, 2020, Abbott announced that the FDA had issued Emergency Use Authorization (EUA) for the company’s…
On Mar. 18, 2020, Mateon Therapeutics reported significant progress in deploying its phase 3 clinical asset, OT-101, against…
On Mar. 18, 2020, Eli Lilly announced its scientists were partnering with the Indiana State Department of Health…
On Mar. 17, 2020, Quidel Corp. announced it had received Emergency Use Authorization (EUA) from the U.S. Food…
On Mar. 17, 2020, BioMedomics announced it will be able to distribute their COVID-19 IgM-IgG Antibody Rapid Test…
On Mar. 17, 2020, Todos Medical announced a non-exclusive distribution agreement with 3D Biomedicine Science & Technology, a…
On Mar. 16, 2020, Aimmune Therapeutics announced that the first patients in the U.S. were being treated with…
On Mar. 16, 2020, Hologic announced the U.S. Food and Drug Administration (FDA) had granted Emergency Use Authorization…
On Mar. 16, 2020, BD (Becton, Dickinson and Company) announced the companies had submitted Emergency Use Authorization requests…
On Mar. 13, 2020, Roche announced the FDA has issued an Emergency Use Authorization for the cobasﾮ SARS-CoV-2…
On Mar. 13, 2020, Thermo Fisher Scientific announced the FDA has issued an emergency use authorization (EUA) for…
On Mar. 9, 2020, the FDA approved Boehringer Ingelheim’s Ofev (nintedanib) oral capsules to treat patients with chronic…
On Mar. 6, 2020, the FDA approved Isturisa (osilodrostat) oral tablets for adults with Cushing’s disease who either…
On Mar. 4, 2020, the UW Medicine Clinical Virology Lab announced it had received U.S. Food and Drug…
On Mar. 2, 2020, Mateon Therapeutics reported the company had been evaluating its therapeutic and AI platforms to…
On Feb. 29, 2020, the University of Washington (UW) Medicine Clinical Virology Lab announced it had received U.S….
On Feb. 28, 2020, the FDA approved an application for the first generic of Daraprim (pyrimethamine) tablets for…
On Feb. 24, 2020, Innovation Pharmaannounced the Company submitted a Material Transfer Agreement (MTA) with a leading U.S.-based…
On Feb. 22, 2020, a federal judge from the Southern District of New York ruled drug companies, device…
On Feb. 21, 2020, the U.S. Food and Drug Administration (FDA) approved NEXLETOL (bempedoic acid) tablet, an oral,…